ION Geophysical Corporation (NYSE:IO) tinted gains of +2.91% (+0.8 points) to US$28.25. The volume of 0.13 Million shares climbed down over an trading activity of 261.68 Million shares. EPS ratio determined by looking at last 12 month figures is -1.92. Over the same time span, the stock marked US$32.45 as its best level and the lowest price reached was US$3.2. The corporation has a market cap of US$396.35 Million.

ION Geophysical Corporation (NYSE:IO)’s earnings per share has been growing at a -19.4 percent rate over the past 5 year when average revenue increase was noted as -17.8 percent. The return on equity ratio or ROE stands at -72 percent while most common profitability ratio return on investment (ROI) was -6.7 percent. The company’s institutional ownership is monitored at 47.8 percent. The company’s net profit margin has achieved the current level of -12.8 percent and possesses 38.5 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 1 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 0 think it is Hold. Recently, analysts have updated the overall rating to 1.5. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.

Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) is worth US$201.24 Million and has recently risen 2.91% to US$5.3. The latest exchange of 0.12 Million shares is below its average trading activity of 131.35 Million shares. The day began at US$0 but the price moved to US$0 at one point during the trading and finally capitulating to a session high of US$0. The stock tapped a 52-week high of US$7.45 while the mean 12-month price target for the shares is US$16.25.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 4.49, and a price to sales ratio of 55.9. For the past 5 years, the company’s revenue has grown 27.6%, while the company’s earnings per share has grown 0%. With an institutional ownership near 54.2%, it carries an earnings per share ratio of -2.06.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 1 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 4 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.8.